OBJECTIVE: To investigate whether changes in anthropometric measures are related to lung function decline. DESIGN: A national 7-y follow up study in Great Britain. SUBJECTS: 3391 adults aged 18 ± 73 y at baseline. MEASUREMENTS: The primary outcome measure was change in forced expiratory volume in one second (D FEV 1 ), adjusted for age, height and sex. This was related to changes in weight, body mass index, waist circumference, hips circumference and waist to hip ratio. RESULTS: Changes in weight, body mass and waist circumference, adjusted for confounders including mean level, were all associated with changes in FEV 1 (P`0.001), with all effects stronger in men than women (P`0.05). Change in waist to hip ratio was related in men (P 0.01), but not in women (P 0.34). A 10 kg weight increase induced an additional fall in FEV 1 of 96 ml (95% con®dence interval (95% CI 65 ± 127 ml) in men, and 51 ml (95% CI. 27 ± 75 ml) in women. In men, the effect increased with average weight and obesity and was more pronounced in middle age. This phenomenon was not present in women, possibly due to gender differences in weight distribution in later adult life. Smoking did not appear to in¯uence the magnitude of effect in either sex. The detrimental effect of weight gain on FEV 1 in subjects that stopped smoking between studies appeared small in comparison to the bene®t of smoking cessation. CONCLUSION: Increases in adult body mass are predictors of FEV 1 decline, especially among older and heavier men, where weight reduction may signi®cantly slow lung function decline.
Introduction
Observational studies have shown the health effects of weight change in adults to be con¯icting. On the one hand, since obesity has been shown to be associated with risk factors for cardiovascular disease, 1 losing weight would be expected to be bene®cial as changes in weight have been shown to be related to changes in these risk factors. 2 For those considered overweight, weight loss has been shown to be associated with lower mortality from cardiovascular disease. 3 However, a review of several studies showed that adults who gain moderate weight over a number of years had lower all-cause mortality rates (including cardiovascular disease) than those who lose or maintain their weight. 4 Only among subjects who gained excessive amounts of weight was all-cause mortality raised.
With regard to lung function the evidence suggests that changes in weight, 1,5 ± 10 or changes in body mass 11 are negatively associated with changes in lung function in adults. Increased levels of forced expiratory volume in one second (FEV 1 ) decline have been shown to be associated with swifter development of chronic obstructive pulmonary disease (COPD), 12 stroke, 13 ischaemic heart disease (IHD) 14 and mortality. 15 It may also be that adjusting for changes in weight is important when investigating other risk factors in a longitudinal analysis of lung function.
In this paper we investigate the longitudinal relationships between adiposity and FEV 1 in a national study of British adults using a selection of physiological measurements made 7 y apart. Anthropometric data have already been published from this study, showing that waist measurements were better indicators of cardiovascular risk than overall body mass. 16 
Methods

The health and lifestyle survey
The Health And Lifestyle Survey (HALS1) consisted of a random sample of 9003 adults resident in England, Scotland or Wales, who were interviewed and measured initially during 1984 and 1985. A follow-up study (HALS2) 7 y later interviewed and remeasured 5352 (59.4%) of the original sample. Further details of the sample selection and data collection for both studies have been published elsewhere. 17, 18 The methods used in both surveys were similar. An interview was carried out in the respondent's home which collected a wide range of information including socio-economic status, self-reported health, dietary habits and smoking history. Individuals were assigned a`household socio-economic group' based on the 1980 Registrar General's classi®cation. 19 This interview was followed by a home visit by a nurse who carried out an array of physiological measurements including height, weight, hips and waist circumference, and respiratory function.
Body measurements and spirometry
Standing height (without shoes) was measured with a portable stadiometer. Weight was taken in stockinged feet with jacket or coat removed, and measured by portable electronic scales. An estimate for remaining clothing was made, to correct for nude weight. 17, 18 Body mass index (BMI) was calculated as weight divided by height squared (kgam 2 ). Waist circumference was measured using a tape placed between the top of the hipbone and the lowest rib. Measurement at the hips was made at the top of iliac crest, but was introduced late in HALS1, and subsequently only available for two-thirds of the sample. 17 Waist hip ratio (WHR) was calculated as the ratio of these two measures.
FEV 1 was measured with an electric turbine spirometer (Micro Medical Instruments, Rochester, England). Calibration of each instrument was carried out at the start of each wave of data collection and rechecked at the end by placing it in series with a Vitalograph spirometer. Measurements were discarded in the few cases that signi®cant calibration drift had occurred.
Following suitable instructions and a practice attempt, each subject performed three forced expiratory manoeuvres. The maximum value of FEV 1 attained is used in the analysis here. Subjects with an acute respiratory infection had their measurements discarded, as did any whose tests were deemed unsatisfactory by the nurse. 17 As previously noted 20 there was probably a systematic underestimation of forced vital capacity (FVC) within the Heath and Lifestyle Survey, so we do not present any analyses of FVC here.
Exclusions
Analyses in this report were restricted to Caucasians who were between 18 and 73 y old at the ®rst survey (HALS1) with satisfactory spirometric measurements at both examinations. Data were too sparse among subjects aged 74 or more at entry.
Height was measured with high measurement error in HALS. 142 (4%) of 3534 subjects with height measurements at both studies (and acceptable lung function) had a change of over 5 cm, while 894 (26%) had a change over 2 cm. We excluded those with a height difference of over 5 cm from our results, however, a further exclusion of those with a difference of over 2 cm made little difference to the magnitude of effects found. Pregnant women were excluded from waist and hips measurements.
Subjects were also excluded if their change in FEV 1 (DFEV) lay outside the middle 99% of the distribution. This left 3391 subjects for analysis, of which 2265 had hip measurements.
Statistical methods
For the purposes of analyses subjects were grouped into ®ve categories based on their smoking history: lifetime never smokers (no report of ever having smoked at least one cigarette a day for as long as six months'), ex-smokers (ex-smokers at HALS1 and not smoked since), current smokers (at both HALS1 and HALS2), quitters (smokers at HALS1 but exsmoker at HALS2) and other smokers (any other permutation).
We used a`two-step' approach to our regressions, identical to a previous analysis on these data. 21 Using annual change in FEV 1 (in litres) as the dependent variable, as some subjects were measured 6 or 8 y apart, we adjusted it for the effects of age (in y) and height (in cm). This was done by using a set of prediction equations that were based on never smokers with no history of respiratory illness throughout (246 males and 497 females). These contained terms for mean age (AGEM) and height at ®rst examination, which is compatible with the form of cross-sectional models used in previous analyses, with height assumed constant. 21 Males: DFEVaDAGE 7 204.6 7 0.578Â AGEM 1.164ÂHT Females: DFEVaDAGE 70.16 7 0.618Â AGEM 7 0.403ÂHT The regression coef®cients from the above equations were used to calculate a set of predicted values and residuals (observed minus predicted). For the purposes of presentation, we multiplied the residuals by 7 to represent the predicted loss over the 7-y interval between examinations. The mean residual DFEV was 7 5 ml for men and 5 ml for women.
To look at the effects of weight change on lung function, we regressed the DFEV residuals on absolute change in weight using PROC GLM in SAS (SAS Institute Inc., North Carolina, USA). The following were included as potential confounding variables ± social class (six household socio-economic groups plus an`other' category), region of residence (nine English regions, Scotland and Wales) and pack-years (estimated as the average consumption times years of smoking given at baseline), and average weight. Average weight was used instead of initial weight, because of the correlation that exists between change and initial value. 22 Adiposity, weight change and ventilatory function IM Carey et al A similar approach was used to look at the effects of change in other body measurements on FEV 1 . We also carried out a regression on a nine level factor based on groups de®ned by initial weight (separate tertiles for men and women) and subsequent weight change (weight loss or no gain, 0.1 ± 5 kg gain and b 5 kg gain).
Results
Change in weight was negatively associated with D FEV in both males and females (P`0.001, Table 1) , with the overall effect being almost twice as great in males (P 0.02 for test of sex interaction). In males, the largest effects were seen for middle aged subjects (ages 32 ± 59 y), while in females it was the youngest who showed the greatest effect (ages 18 ± 31 y). There was no clear pattern of differing effects across smoking categories in either sex. Men who had experienced respiratory illness between studies for the ®rst time suffered signi®cantly worse effects of weight gain, while women did not.
The effects of weight change (three categories: 0 kg or less, 0 ± 5 kg, 5 kg) by initial weight thirds in men and women separately are shown in Table 2 . In men, the effect of weight change increases with increasing initial weight. This phenomenon was also present for BMI, waist and hip circumference in men (not shown), but not seen at all in women. An increase of 5 kg or more in weight has a similar effect among women at the extremes of weight. Table 3 compares the effect of a 1 s.d. increase in both average and change in weight, BMI, waist circumference, hip circumference and WHR on DFEV. For change in weight, BMI and waist circumference the pattern is: the effect is comparable for younger men and women, but in older men it doubles whilst staying roughly the same in women. Change in hip circumference is only related in women (P`0.001), while change in WHR shows a relationship only in older men (P`0.001). Average levels of measurement are generally unrelated, except for average weight in younger men.
Discussion
In a national study of British adults, we have demonstrated longitudinal relationships between changes in weight (and other body measurements) and changes in lung function, and shown that the nature and magnitude of effect may differ between men and women.
Cross-sectional relationships between FEV 1 and weight
The cross-sectional relationship of weight with lung function is non-linear (`U-shaped'), in the sense that maximal function is achieved at near ideal body weight. 5, 10, 23, 24 The usual interpretation is that lung function increases initially with weight, highlighting à muscularity effect', and then falls with further increases in weight representing an`obesity effect'. 23 Similar trends were seen at both HALS1 Table 1 The effect of a 10 kg increase in weight on DFEV (difference between observed and predicted change in FEV 1 in ml) over 7 y (n 3391) Additionally adjusted for average weight. and HALS2 (not shown). Adjusting lung function for weight should, therefore, take account of this nonlinearity.
Changes in weight vs changes in FEV 1
In the few studies that have looked at it, a consistent effect of weight or body mass change on FEV 1 change has been found. 1,5 ± 11 In the two studies with both men and women, signi®cantly higher effects were found in men. 5, 7 Age and height may also be important factors in this relationship, as Bande and colleagues 10 showed that within their younger (mean age 20 y) and taller subjects, changes in weight tended to increase FVC and FEV 1 while the effect was reversed in older and shorter subjects. However, in the Normative Ageing Study, larger effects of weight gain on FVC decrease were found in younger subjects. 1 Baseline obesity may also in¯uence the effect as Dontas et al 6 only found a signi®cant trend of BMI change on FVC in their heaviest subjects. Other small studies of obese subjects have found signi®cant short-term improvement in lung function with weight loss. 25 ± 27 In HALS we found that change in weight was negatively related to change in FEV 1 , which remained signi®cant when adjusted for average weight (P`0.001). This negative effect was seen in all sub-groups of age and height, and we found no evidence that changes were positively associated with FEV 1 change in our youngest or tallest subjects. We estimate that a 10 kg increase in weight over 7 y induced an additional fall of 96 ml (65 ± 127) in men an 51 ml (27 ± 75) in women, with the gender difference being signi®cant (P 0.02). The effect in men was stronger among the heaviest and obese at HALS1. Those that started off heavy or overweight suffered far greater losses of FEV 1 by gaining weight than those who were normal or underweight at HALS1. Subjects who lost weight between studies did not on average gain lung function, but rather slowed down their rate of decline in comparison to others.
The magnitudes of effect compare well with other studies. For instance, Chinn et al 11 found that among 772 male shipyard workers aged 45 ± 70, a 1 kg increase in weight over roughly 7 y was associated with a decrease in FEV 1 of 17.6 ml. In a multi-centre trial of smoking cessation (n 5436), Wise et al 5 found that a 1 kg increase in weight was associated with increased annual declines of 711.1, 76.2, 79.7 mlay in their male quitters, intermittent and continuing smokers respectively, and declines of 75.6, 70.7, 74.2 mlay for women similarly.
We did not present any analyses using FVC here because of the systematic underestimation that took place in HALS. 20 However, these biased measurements produced similar magnitudes of effect with weight gain as those seen with FEV 1 (data not shown).
Sex difference
The impact of changes in weight and body mass appears stronger in men, with the difference largely attributable to the exaggerated effect in older men. The distribution of weight during middle age is different for men and women. Men tend to put on weight around their waist, while women increase in size around their hips. Thus increases in abdominal fat (and visceral fat) with weight gain, which are greater in men, may be the underlying cause of lung function impairment and decline, 5 and explain why this sex difference is found.
Our data generally support this hypothesis. Firstly, although men and women had comparable increases in waist circumference, larger increases in women's hips resulted in greater increases in WHR for men (not shown). Weight change showed a stronger association with change in WHR in men than women, especially in older subjects (Pearson's correlation coef®cient r 0.37 to 0.13 in 46 ± 73 year olds). Changes in WHR were signi®cant predictors of FEV 1 decline in men (P 0.01), while they were not related in women (P 0.34). WHR is thought to estimate the volume of abdominal visceral tissue more effectively than BMI. 28 In a small study of weight loss, Wing et al 29 also found weight change to be correlated higher with WHR in men than women (0.63 ± 0.31). However, in that study men were found to have comparable changes in their hips with women, but had greater changes in their waist circumference.
Weight gain vs smoking cessation
Smoking cessation has been shown to improve an individual's rate of FEV 1 decline to that of a nonsmoker within a few years, 30 ± 34 but is also associated with increases in weight. 5, 35 Thus, the lung function bene®ts of cessation may be offset or reduced by weight gain, at least in the short term.
Estimates vary about the respective magnitudes of these competing effects. Wise et al 5 estimate that a sustained quitter would have to gain about 60 kg weight (over 7 y) to have the same effect on FEV 1 as continuing their habit. However, Wang et al 8 estimate that the effect of gaining 1 lb in weight (2.2 kg) per y on FEV 1 decline was equivalent to about a third of that incurred by smoking in their study.
In HALS, the small number of subjects who ceased smoking between studies gained more weight than any other smoking group (on average 2.5 kg more than continuing smokers for men), and the effects of weight change on FEV 1 was comparable between them and other smoking groups. Between studies, middle-aged men who continued to smoke lost roughly 100 ml more FEV 1 than non-smokers ± the equivalent to gaining 10 kg. Thus the bene®ts of smoking cessation for middle aged men in HALS are reduced by approximately a quarter because of subsequent weight gain.
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Conclusions
Changes in weight or body mass are related to changes in FEV 1 . The effects are stronger in men, probably due to the relative increase in abdominal fat. Among men, the detrimental effects of weight gain appear stronger among the heaviest and most obese, suggesting that weight reduction in these subjects can signi®cantly reduce their rates of FEV 1 decline.
